tiprankstipranks

Top UK Pharma & Biotech Shares

Compare UK pharmaceutical companies and biotech shares. See a comparison of key indicators, including pharma stock price targets and analyst recommendations.
Compare up to 10 stocks or ETFs

Comparison Results

Name
Price
Price Change
Volume
Market Cap
Analyst Price Target
Analyst Consensus
Smart Score
Article
Follow
GB:AZN
AstraZeneca
12088.00p
7p
(0.06%)
106.66K£187.73B
10 Buy
4 Hold
1 Sell
Moderate Buy
GB:GSK
GlaxoSmithKline
1775.00p
3.25p
(0.18%)
447.25K£72.38B
8 Buy
4 Hold
2 Sell
Moderate Buy
GB:HIK
Hikma Pharmaceuticals
1970.00p
14p
(0.71%)
16.76K£4.39B
2 Buy
5 Hold
0 Sell
Moderate Buy
GB:HCM
HUTCHMED (China) Limited
324.00p
13p
(3.86%)
104.37K£2.79B
2 Buy
0 Hold
0 Sell
Moderate Buy
GB:DPH
DPH

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
GB:AZN
AstraZeneca
12,110.00
335.96
2.85%
GB:GSK
GlaxoSmithKline
1,775.00
402.86
29.36%
GB:HIK
Hikma Pharmaceuticals
1,978.00
188.14
10.51%
GB:HCM
HUTCHMED (China) Limited
324.00
106.00
48.62%
GB:DPH
3,866.00
692.00
21.80%
Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Pharma & Biotech Stocks Latest News

Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Pharma & Biotech Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
GlaxoSmithKline
Buy
Reiterated
Hikma Pharmaceuticals
Hold
Reiterated
HUTCHMED (China) Limited
Buy
Initiated
GlaxoSmithKline
Buy
Reiterated

Most Recent Earnings of Pharma & Biotech Stocks

Name
Report Date
Time Of Day
Period Ending
Forecast / EPS
Last Year's EPS
AstraZeneca
Apr 25, 2024
Mar 01, 2024
150.40 / 162.13
215
GlaxoSmithKline
May 01, 2024
Mar 01, 2024
36.70 / 43.10
38.8
Hikma Pharmaceuticals
Feb 22, 2024
Dec 01, 2023
- / 21.40
127.9
HUTCHMED (China) Limited
Feb 28, 2024
Dec 01, 2023
-17.00 / -11.02
1.917
DPH
- / -

Pharma & Biotech Stocks - FAQ

Which Pharma & Biotech stocks have a "Strong Buy" analyst rating?
These Pharma & Biotech stocks currently have a "Strong Buy" analyst rating consensus:
None of the selected stocks have a “Strong Buy” analyst rating consensus.
    Are Pharma & Biotech stocks overpriced?
    AstraZeneca's stock price is currently 12,088.00p, and its average 12-month price target is 12,355.27p.
      GlaxoSmithKline's stock price is currently 1,775.00p, and its average 12-month price target is 1,939.10p.
        Hikma Pharmaceuticals's stock price is currently 1,970.00p, and its average 12-month price target is 2,210.71p.
          HUTCHMED (China) Limited's stock price is currently 324.00p, and its average 12-month price target is 353.13p.
            's stock price is currently N/A, and its average 12-month price target is N/A.
              Which Pharma & Biotech stocks pay dividends?
              AstraZeneca does not currently pay dividends.
                GlaxoSmithKline does not currently pay dividends.
                  Hikma Pharmaceuticals does not currently pay dividends.
                    HUTCHMED (China) Limited does not currently pay dividends.
                      does not currently pay dividends.

                        Latest News​

                        Jonathan MorganTether Injects $1 Billion Worth of USDT into Market
                        Steve AndersonIntact Financial Corp (TSE:IFC) Works to Fight Wildfires Before They Start
                        Shrilekha PetheM&A News: Overseas Shipholding (NYSE:OSG) Surges on $950M Acquisition by Satchuk
                        Shrilekha PetheTarget (NYSE:TGT) Slashes Prices on Over 5,000 Items
                        Jonathan MorganDevelopers Bet “Programmability” Could Ignite Bitcoin’s Next Rally
                        Paul HoffmanVIX Lows: A Rare Moment of Market Calm that Investors Love
                        Shrilekha PetheNovo Nordisk: Genetic Profile Predicts Success with Wegovy
                        Radhika SaraogiFITLX, CMJAX: 2 ESG Funds with Over 10% Upside Potential, According to Analysts
                        Shrilekha PetheWIX Earnings: Wix.com Jumps on Robust Q1 Results
                        Kirti TakRyanair Stock: Profits Beat Expectations; Company Announces Buyback
                        Amit SinghWho Owns Palantir Stock?
                        Radhika SaraogiInsider Trading: Transocean Stock Gains on Huge Insider Buy
                        Amit SinghApple Emulates Tesla by Cutting Prices to Spur Demand in China
                        TipRanks NewsdeskOptions Volatility and Implied Earnings Moves Today, May 20, 2024
                        TipRanks NewsdeskOptions Volatility and Implied Earnings Moves This Week, May 20 – May 23, 2024

                        Pharma & Biotech Stock Events

                        Stock
                        Type
                        Date
                        AstraZeneca
                        Earnings ReleaseJul 25, 2024
                        GlaxoSmithKline
                        Earnings ReleaseJul 31, 2024
                        HUTCHMED (China) Limited
                        Earnings ReleaseJul 31, 2024
                        Hikma Pharmaceuticals
                        Earnings ReleaseAug 08, 2024
                        Dechra Pharmaceuticals
                        Earnings ReleaseSep 02, 2024

                        Popular Stocks

                        Company
                        Price & Change
                        Follow
                        Nvidia
                        Apple
                        Microsoft